Clinical Trials
3 trialsNCT02174549 2026-04-20
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Teclison Ltd.
Phase 1/2 Recruiting
NCT06848556 2025-02-27
Evaluate the Effect of Tirazamine on Primary Liver Cancer.
Zhejiang Raygene Pharmaceuticals Co., Ltd
Phase 1/2 Terminated
NCT03145558 2024-11-22
TATE
Teclison Ltd.
Phase 2 Terminated